Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 1
1999 1
2000 1
2005 1
2006 1
2008 1
2009 1
2010 1
2014 1
2015 2
2016 2
2017 2
2018 3
2019 3
2020 6
2021 5
2022 2
2023 9
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer.
Prager GW, Taieb J, Fakih M, Ciardiello F, Van Cutsem E, Elez E, Cruz FM, Wyrwicz L, Stroyakovskiy D, Pápai Z, Poureau PG, Liposits G, Cremolini C, Bondarenko I, Modest DP, Benhadji KA, Amellal N, Leger C, Vidot L, Tabernero J; SUNLIGHT Investigators. Prager GW, et al. N Engl J Med. 2023 May 4;388(18):1657-1667. doi: 10.1056/NEJMoa2214963. N Engl J Med. 2023. PMID: 37133585 Clinical Trial.
Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer.
Fizazi K, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I, Kappeler C, Snapir A, Sarapohja T, Smith MR; ARAMIS Investigators. Fizazi K, et al. N Engl J Med. 2019 Mar 28;380(13):1235-1246. doi: 10.1056/NEJMoa1815671. Epub 2019 Feb 14. N Engl J Med. 2019. PMID: 30763142 Clinical Trial.
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial.
Rha SY, Oh DY, Yañez P, Bai Y, Ryu MH, Lee J, Rivera F, Alves GV, Garrido M, Shiu KK, Fernández MG, Li J, Lowery MA, Çil T, Cruz FM, Qin S, Luo S, Pan H, Wainberg ZA, Yin L, Bordia S, Bhagia P, Wyrwicz LS; KEYNOTE-859 investigators. Rha SY, et al. Lancet Oncol. 2023 Nov;24(11):1181-1195. doi: 10.1016/S1470-2045(23)00515-6. Epub 2023 Oct 21. Lancet Oncol. 2023. PMID: 37875143 Clinical Trial.
Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide.
Fizazi K, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I, Le Berre MA, Petrenciuc O, Snapir A, Sarapohja T, Smith MR; ARAMIS Investigators. Fizazi K, et al. N Engl J Med. 2020 Sep 10;383(11):1040-1049. doi: 10.1056/NEJMoa2001342. N Engl J Med. 2020. PMID: 32905676 Clinical Trial.
Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, open-label phase II study.
O'Shaughnessy J, Sousa S, Cruz J, Fallowfield L, Auvinen P, Pulido C, Cvetanovic A, Wilks S, Ribeiro L, Burotto M, Klingbiel D, Messeri D, Alexandrou A, Trask P, Fredriksson J, Machackova Z, Stamatovic L; PHranceSCa study group. O'Shaughnessy J, et al. Eur J Cancer. 2021 Jul;152:223-232. doi: 10.1016/j.ejca.2021.03.047. Epub 2021 Jun 16. Eur J Cancer. 2021. PMID: 34147014 Free article. Clinical Trial.
Diagnostic Accuracy of Dermoscopy of Actinic Keratosis: A Systematic Review.
Valdés-Morales KL, Peralta-Pedrero ML, Cruz FJ, Morales-Sánchez MA. Valdés-Morales KL, et al. Among authors: cruz fj. Dermatol Pract Concept. 2020 Oct 26;10(4):e2020121. doi: 10.5826/dpc.1004a121. eCollection 2020 Oct. Dermatol Pract Concept. 2020. PMID: 33150042 Free PMC article. Review.
Keratosis Pilaris Treatment: Evidence from Intervention Studies.
Suástegui-Rodríguez I, Camacho-Rosas LH, Peralta-Pedrero ML, Cruz FJ, Morales-Sánchez MA. Suástegui-Rodríguez I, et al. Among authors: cruz fj. Skinmed. 2022 Aug 31;20(4):258-271. eCollection 2022. Skinmed. 2022. PMID: 35976015
Dose-Adjusted FRAX Score in Pemphigus Vulgaris Treatment.
Guzmán-Herrera S, Morales-Sánchez MA, Peralta-Pedrero ML, de Peña-Ortiz J, Cruz FJS. Guzmán-Herrera S, et al. Among authors: cruz fjs. Indian J Dermatol. 2023 Nov-Dec;68(6):698-700. doi: 10.4103/ijd.ijd_1061_20. Epub 2024 Jan 9. Indian J Dermatol. 2023. PMID: 38371552 Free PMC article. No abstract available.
Methodological quality of clinical trials of keloid scars.
Morales-Sánchez MA, De Villafranca-Dugelby A, Cruz FJ, Peralta-Pedrero ML. Morales-Sánchez MA, et al. Among authors: cruz fj. Cir Cir. 2020;88(5):591-598. doi: 10.24875/CIRU.20001506. Cir Cir. 2020. PMID: 33064692 Free article. English.
40 results